AR012437A1 - Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion - Google Patents

Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion

Info

Publication number
AR012437A1
AR012437A1 ARP980101734A ARP980101734A AR012437A1 AR 012437 A1 AR012437 A1 AR 012437A1 AR P980101734 A ARP980101734 A AR P980101734A AR P980101734 A ARP980101734 A AR P980101734A AR 012437 A1 AR012437 A1 AR 012437A1
Authority
AR
Argentina
Prior art keywords
procedure
manufacture
preparation
compounds
pharmaceutical composition
Prior art date
Application number
ARP980101734A
Other languages
English (en)
Spanish (es)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR012437A1 publication Critical patent/AR012437A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP980101734A 1997-04-16 1998-04-15 Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion AR012437A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84348497A 1997-04-16 1997-04-16

Publications (1)

Publication Number Publication Date
AR012437A1 true AR012437A1 (es) 2000-10-18

Family

ID=25290123

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101734A AR012437A1 (es) 1997-04-16 1998-04-15 Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion

Country Status (19)

Country Link
EP (1) EP0975633A1 (ja)
JP (1) JP2001520654A (ja)
KR (1) KR20010006462A (ja)
CN (1) CN1252069A (ja)
AR (1) AR012437A1 (ja)
AU (1) AU741033B2 (ja)
BG (1) BG103853A (ja)
BR (1) BR9809056A (ja)
CA (1) CA2286592A1 (ja)
CO (1) CO4940470A1 (ja)
HU (1) HUP0001443A3 (ja)
IL (1) IL131617A0 (ja)
NO (1) NO995035L (ja)
NZ (1) NZ337125A (ja)
PL (1) PL336265A1 (ja)
SK (1) SK140099A3 (ja)
TR (1) TR199902550T2 (ja)
WO (1) WO1998046604A1 (ja)
ZA (1) ZA983175B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
IL156872A0 (en) 2001-02-12 2004-02-08 Hoffmann La Roche 6-substituted pyrido-pyrimidines
CN107744520A (zh) * 2017-10-25 2018-03-02 南京多宝生物科技有限公司 嘧啶类化合物在制备促进小肠蠕动药物中的应用
CN112209924B (zh) * 2019-07-09 2022-04-05 中国科学院天津工业生物技术研究所 选择性腺苷a1受体拮抗剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
KR20010006462A (ko) 2001-01-26
SK140099A3 (en) 2000-05-16
JP2001520654A (ja) 2001-10-30
ZA983175B (en) 1998-10-21
AU7108098A (en) 1998-11-11
HUP0001443A2 (hu) 2000-10-28
NZ337125A (en) 2001-06-29
WO1998046604A1 (en) 1998-10-22
CN1252069A (zh) 2000-05-03
CA2286592A1 (en) 1998-10-22
TR199902550T2 (xx) 2000-04-21
HUP0001443A3 (en) 2001-01-29
NO995035D0 (no) 1999-10-15
AU741033B2 (en) 2001-11-22
BR9809056A (pt) 2000-08-01
PL336265A1 (en) 2000-06-19
CO4940470A1 (es) 2000-07-24
NO995035L (no) 1999-12-15
BG103853A (en) 2000-06-30
IL131617A0 (en) 2001-01-28
EP0975633A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
PT100631A (pt) Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem
ES2059602T3 (es) Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
CA2098076A1 (en) Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates
RU2004130488A (ru) Пиримидиновые производные
UY25225A1 (es) Derivados de pleuromutilina utiles como agentes antimicrobianos
RU94016183A (ru) Производные пиперазина
AR012436A1 (es) Compuestos de 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos, composicion farmaceutica que los comprende, el uso de los mismos para lamanufactura de medicamentos, un procedimiento para su preparacion.
OA09454A (fr) Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES2046193T3 (es) Un procedimiento para la preparacion de un compuesto de imidazolidinona.
AR012437A1 (es) Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion
AR040233A1 (es) Polimorfos inhibidores de xantina fosfodiesterasa v
EA200100597A2 (ru) Новые 1,1- и 1,2-дизамещенные циклопропановые соединения, способ их получения и содержащие их фармацевтические композиции
AR012435A1 (es) Compuesto de 4-aminopirido[2,3-d]pirimidina 6,7-disustituida; el uso del mismo para la manufactura de un medicamento, procedimiento para su preparacion,composicion farmaceutica que lo contiene, compuestos intermediarios y procedimiento para su preparacion.
ATE144423T1 (de) Therapeutische benzazepin verbindungen
MX9300423A (es) Derivados heterociclicos.
RU96102846A (ru) Производные изохинолина в качестве терапевтических средств
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
ES477257A1 (es) Un procedimiento para preprarar derivados de isoquinoleina.
RU2021107688A (ru) Трициклические соединения, действующие на белки crbn
UY28119A1 (es) Nuevos derivados que contienen fosforo
KR970706258A (ko) 4a-아릴데카히드로이소키노린 화합물 및 그 의약 용도(4a-ARYLDECAHYDROISOQUINOLIN COMPOUND AND MEDICINAL USE OF THE SAME)
AR030196A1 (es) Compuesto que contiene cadena lateral carbociclica, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento
GB1455617A (en) Pyran derivatives
TH13800A (th) อนุพันธ์ชนิดใหม่ของเพพไทด์

Legal Events

Date Code Title Description
FB Suspension of granting procedure